These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Immunological and metabolic effects of cis-9, trans-11-conjugated linoleic acid in subjects with birch pollen allergy. Turpeinen AM; Ylönen N; von Willebrand E; Basu S; Aro A Br J Nutr; 2008 Jul; 100(1):112-9. PubMed ID: 18167173 [TBL] [Abstract][Full Text] [Related]
63. Recombinant marker allergens in diagnosis of patients with allergic rhinoconjunctivitis to tree and grass pollens. Canis M; Gröger M; Becker S; Klemens C; Kramer MF Am J Rhinol Allergy; 2011; 25(1):36-9. PubMed ID: 21711974 [TBL] [Abstract][Full Text] [Related]
64. The influence of birch pollination on the adenoid size in children with intermittent allergic rhinitis. Modrzynski M; Zawisza E Int J Pediatr Otorhinolaryngol; 2007 Jul; 71(7):1017-23. PubMed ID: 17482282 [TBL] [Abstract][Full Text] [Related]
65. Exposure to birch pollen in infancy and development of atopic disease in childhood. Kihlström A; Lilja G; Pershagen G; Hedlin G J Allergy Clin Immunol; 2002 Jul; 110(1):78-84. PubMed ID: 12110825 [TBL] [Abstract][Full Text] [Related]
66. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830 [TBL] [Abstract][Full Text] [Related]
67. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study. Horak F; Stübner P; Berger UE; Marks B; Toth J; Jäger S J Investig Allergol Clin Immunol; 1998; 8(3):165-71. PubMed ID: 9684190 [TBL] [Abstract][Full Text] [Related]
68. Randomized open comparison of montelukast and sublingual immunotherapy as add-on treatment in moderate persistent asthma due to birch pollen. Marogna M; Colombo F; Spadolini I; Massolo A; Berra D; Zanon P; Chiodini E; Canonica GW; Passalacqua G J Investig Allergol Clin Immunol; 2010; 20(2):146-52. PubMed ID: 20461969 [TBL] [Abstract][Full Text] [Related]
69. London Plane Tree bioaerosol exposure and allergic sensitization in Sydney, Australia. Sercombe JK; Green BJ; Rimmer J; Burton PK; Katelaris CH; Tovey ER Ann Allergy Asthma Immunol; 2011 Dec; 107(6):493-500. PubMed ID: 22123378 [TBL] [Abstract][Full Text] [Related]
70. A follow-up study of immunotherapy-treated birch-allergic patients: effect on the expression of chemokines in the nasal mucosa. Plewako H; Holmberg K; Oancea I; Gotlib T; Samoliński B; Rak S Clin Exp Allergy; 2008 Jul; 38(7):1124-31. PubMed ID: 18691293 [TBL] [Abstract][Full Text] [Related]
71. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis. Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092 [TBL] [Abstract][Full Text] [Related]
72. Efficacy, safety, and immunological effects of a 2-year immunotherapy with Depigoid birch pollen extract: a randomized, double-blind, placebo-controlled study. Höiby AS; Strand V; Robinson DS; Sager A; Rak S Clin Exp Allergy; 2010 Jul; 40(7):1062-70. PubMed ID: 20642579 [TBL] [Abstract][Full Text] [Related]
73. Topical dsRNA challenges may induce overexpression of airway antiviral cytokines in symptomatic allergic disease. A pilot in vivo study in nasal airways. Brandelius A; Andersson M; Uller L Respir Med; 2014 Dec; 108(12):1816-9. PubMed ID: 25456711 [TBL] [Abstract][Full Text] [Related]
75. Reported symptoms to peanut between 4 and 8 years among children sensitized to peanut and birch pollen - results from the BAMSE birth cohort. Asarnoj A; Ostblom E; Ahlstedt S; Hedlin G; Lilja G; van Hage M; Wickman M Allergy; 2010 Feb; 65(2):213-9. PubMed ID: 19712120 [TBL] [Abstract][Full Text] [Related]
76. Nasal corticosteroid treatment reduces substance P levels in tear fluid in allergic rhinoconjunctivitis. Callebaut I; Vandewalle E; Hox V; Bobic S; Jorissen M; Stalmans I; De Vries A; Scadding G; Hellings PW Ann Allergy Asthma Immunol; 2012 Aug; 109(2):141-6. PubMed ID: 22840257 [TBL] [Abstract][Full Text] [Related]
77. Characteristics of the Chiba environmental challenge chamber. Hamasaki S; Okamoto Y; Yonekura S; Okuma Y; Sakurai T; Iinuma T; Yamamoto H; Sakurai D; Horiguchi S; Yokota M Allergol Int; 2014 Mar; 63(1):41-50. PubMed ID: 24368583 [TBL] [Abstract][Full Text] [Related]
78. Maternal pollen allergy may be more important than birch pollen exposure during pregnancy for atopic airway disease in the child. Kihlström A; Lilja G; Pershagen G; Hedlin G Pediatr Allergy Immunol; 2004 Dec; 15(6):497-505. PubMed ID: 15610362 [TBL] [Abstract][Full Text] [Related]
79. Tolerability and clinical outcome of coseasonal treatment with Escherichia coli strain Nissle 1917 in grass pollen-allergic subjects. Dölle S; Berg J; Rasche C; Worm M Int Arch Allergy Immunol; 2014; 163(1):29-35. PubMed ID: 24247760 [TBL] [Abstract][Full Text] [Related]
80. The long-range transport of birch (Betula) pollen from Poland and Germany causes significant pre-season concentrations in Denmark. Skjøth CA; Sommer J; Stach A; Smith M; Brandt J Clin Exp Allergy; 2007 Aug; 37(8):1204-12. PubMed ID: 17651151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]